Stryker Co. (NYSE:SYK) Receives $421.90 Average Target Price from Analysts

Stryker Co. (NYSE:SYK) has been given a consensus rating of “Moderate Buy” by the twenty brokerages that are currently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $421.90.

Several research firms have commented on SYK. JMP Securities reissued a “market perform” rating on shares of Stryker in a report on Tuesday, February 18th. Barclays boosted their price objective on shares of Stryker from $418.00 to $443.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. Morgan Stanley raised Stryker from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $370.00 to $445.00 in a report on Monday, December 2nd. Wells Fargo & Company boosted their price target on Stryker from $427.00 to $435.00 and gave the stock an “overweight” rating in a report on Wednesday, January 29th. Finally, The Goldman Sachs Group set a $422.00 price objective on Stryker in a research note on Tuesday, March 4th.

Insider Activity

In other news, Director Ronda E. Stryker sold 201,392 shares of the company’s stock in a transaction on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the sale, the director now directly owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the transaction, the director now directly owns 14,895 shares of the company’s stock, valued at $5,705,827.65. This represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Institutional Trading of Stryker

A number of institutional investors have recently bought and sold shares of SYK. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Stryker during the 4th quarter valued at about $25,000. Capital A Wealth Management LLC acquired a new position in Stryker in the fourth quarter valued at approximately $26,000. Dunhill Financial LLC boosted its holdings in shares of Stryker by 94.9% during the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after buying an additional 37 shares in the last quarter. Rakuten Securities Inc. grew its position in shares of Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company’s stock worth $28,000 after buying an additional 68 shares during the period. Finally, Centricity Wealth Management LLC bought a new stake in shares of Stryker in the 4th quarter valued at $30,000. Institutional investors own 77.09% of the company’s stock.

Stryker Trading Down 1.2 %

Shares of SYK stock opened at $373.69 on Friday. The stock has a market cap of $142.59 billion, a P/E ratio of 48.16, a price-to-earnings-growth ratio of 2.93 and a beta of 0.95. Stryker has a 1 year low of $314.93 and a 1 year high of $406.19. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. The stock has a 50 day simple moving average of $384.18 and a 200 day simple moving average of $373.85.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the prior year, the business posted $3.46 earnings per share. On average, research analysts predict that Stryker will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.90%. The ex-dividend date is Monday, March 31st. Stryker’s payout ratio is presently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.